Zafemy Patch
Product Images NDC 42291-930

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Zafemy (NDC 42291-930). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (930 01)

This is a description of Zafemy, a transdermal contraceptive system that contains norelgestromin and ethinyl estradiol in the amount of 150/35 mcg per day. The product is indicated only for transdermal use and is offered in a 1-week therapy pack. The given NDC (National Drug Code) number is 4220193001. No further information or details about the product are provided.*

FDA Label Image

3 (930 03)

FDA Label Image

Where To Put Patch (Zafemy Norelgestromin And Ethinyl Estradiol Transd 1)

FDA Label Image

Figure 4 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 10)

Not available.*

FDA Label Image

Figure 5 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 11)

FDA Label Image

Figure 6 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 12)

FDA Label Image

01 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 13)

FDA Label Image

02 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 14)

This text appears to be a calendar, but the format is not clear due to errors. The days of the week are readable as "Sunday, Monday, Tuesday, Wednesday, Thursday, Friday, Saturday." However, the format of the calendar is not clear, and the text "Day8 wei" and "Day15s wed" do not provide any useful information. The text at the bottom of the page reads "NOPATCH."*

FDA Label Image

03 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 15)

FDA Label Image

Figure A (Zafemy Norelgestromin And Ethinyl Estradiol Transd 16)

FDA Label Image

Figure B (Zafemy Norelgestromin And Ethinyl Estradiol Transd 17)

FDA Label Image

Where To Put Patch (Zafemy Norelgestromin And Ethinyl Estradiol Transd 18)

FDA Label Image

Usage Illustration 1 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 19)

FDA Label Image

Usage Illustration 1 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 2)

FDA Label Image

Usage Illustration 2 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 20)

FDA Label Image

Usage Illustration 3 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 21)

FDA Label Image

Usage Illustration 4 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 22)

FDA Label Image

Usage Illustration 2 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 3)

FDA Label Image

Usage Illustration 3 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 4)

FDA Label Image

Usage Illustration 4 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 5)

FDA Label Image

Figure 2 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 6)

This text appears to be a table presenting data on the occurrence of blood clots in women according to their pregnancy status and time since delivery. It includes information on the number of women per 10,000 woman-years who experienced blood clots, categorized by pregnancy status (non-pregnant, pregnancy, and postpartum) and time since delivery. There are also some numerical ranges provided without further context.*

FDA Label Image

1 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 7)

This appears to be a list of studies conducted on the risk of breast cancer with combined oral contraceptive use. The list includes the names of the studies, the year they were conducted, and the effect estimates obtained from each study. There are also some numerical values listed at the bottom, but without context, it's unclear what they represent.*

FDA Label Image

Structural Formula (Zafemy Norelgestromin And Ethinyl Estradiol Transd 8)

FDA Label Image

Figure 3 (Zafemy Norelgestromin And Ethinyl Estradiol Transd 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.